SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-132419
Filing Date
2016-11-08
Accepted
2016-11-08 16:09:09
Documents
3
Period of Report
2016-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v452487_8k.htm 8-K 14380
2 EXHIBIT 99.1 v452487_ex99-1.htm EX-99.1 154792
3 GRAPHIC logo.jpg GRAPHIC 32316
  Complete submission text file 0001144204-16-132419.txt   214968
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 161981376
SIC: 2834 Pharmaceutical Preparations